ONYX PHARMACEUTICALS INC – 10-Q – Management’s Discussion and Analysis of Financial Condition and Results of Operations
by on Wednesday, August 10th, 2011 | No Comments
… that target the molecular mechanisms that cause cancer. Through our internal research programs and in … cancer, including lung, thyroid, breast, ovarian and colon cancers. We and Bayer are commercializing Nexavar, …